Manipulating the surface coating of ultra-small Gd2O3 nanoparticles for improved T1-weighted MR imaging

Biomaterials

Volumn 35, Issue 5, 2014, Pages 1636-1642

  Fang, Jie ^a   Chandrasekharan, Prashant ^b   Liu, Xiao Li ^a   Yang, Yong ^a   Lv, Yun Bo ^a   Yang, Chang Tong ^b   Ding, Jun ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

Author keywords

Contrast agent; Gd2O3 nanoparticles; Ligand exchange; MR imaging; Polyvinyl pyrrolidone

Indexed keywords

AVERAGE PARTICLE SIZE; CETYLTRIMETHYLAMMONIUM BROMIDE; CONTRAST AGENT; HYDROPHILIC COATINGS; LIGAND EXCHANGES; MR IMAGING; NANOPARTICLE SURFACE; POLY VINYL PYRROLIDONE;

CARDIOVASCULAR SYSTEM; COATINGS; HYDROPHILICITY; MAGNETIC RESONANCE IMAGING; NANOPARTICLES;

SYNTHESIS (CHEMICAL);

CETRIMIDE; GADOLINIUM PENTETATE MEGLUMINE; NANOPARTICLE; OLEIC ACID; POVIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CIRCULATION TIME; CONTROLLED STUDY; CYTOTOXICITY TEST; DECOMPOSITION; FEMALE; HUMAN; HUMAN CELL; MATERIAL COATING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; RELAXATION TIME; SURFACE PROPERTY; SYNTHESIS;

CONTRAST AGENT; GD(2)O(3) NANOPARTICLES; LIGAND EXCHANGE; MR IMAGING; POLYVINYL PYRROLIDONE;

ANIMALS; CELL LINE; GADOLINIUM; HETEROGRAFTS; HUMANS; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; MICE; MICE, SCID; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES;

EID: 84890158834     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.032     Document Type: Article

References (40)

1. Choi J.-S., Lee J.-H., Shin T.-H., Song H.-T., Kim E.Y., Cheon J. Self-confirming "AND" logic nanoparticles for fault-free MRI. JAm Chem Soc 2010, 132:11015-11017.
2. Srinivas M., Cruz L.J., Bonetto F., Heerschap A., Figdor C.G., de Vries I.J.M. Customizable, multi-functional fluorocarbon nanoparticles for quantitative invivo imaging using (19)F MRI and optical imaging. Biomaterials 2010, 31:7070-7077.
3. Yang M., Cheng K., Qi S., Liu H., Jiang Y., Jiang H., et al. Affibody modified and radiolabeled gold-Iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials 2013, 34:2796-2806.
4. Sun Y., Liu Q., Peng J., Feng W., Zhang Y., Yang P., et al. Radioisotope post-labeling upconversion nanophosphors for invivo quantitative tracking. Biomaterials 2013, 34:2289-2295.
5. Hu F., Zhao Y.S. Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes. Nanoscale 2012, 4:6235-6243.
6. Zabow G., Dodd S., Moreland J., Koretsky A. Micro-engineered local field control for high-sensitivity multispectral MRI. Nature 2008, 453:1058-1063.
7. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 2133-2148.
8. Na H.B., Hyeon T. Nanostructured T1 MRI contrast agents. JMater Chem 2009, 19:6267-6273.
9. Chen F., Bu W.B., Zhang S.J., Liu X.H., Liu J.N., Xing H.Y., et al. Positive and negative lattice shielding effects co-existing in Gd(III) ion doped bifunctional upconversion nanoprobes. Adv Funct Mater 2011, 21:4285-4294.
10. Hifumi H., Yamaoka S., Tanimoto A., Citterio D., Suzuki K. Gadolinium-based hybrid nanoparticles as a positive MR contrast agent. JAm Chem Soc 2006, 128:15090-15091.
11. Lentschig M.G., Reimer P., Rausch-Lentschig U.L., Allkemper T., Oelerich M., Laub G. Breath-hold gadolinium-enhanced MR angiography of the major vessels at 1.0 T: dose-response findings and angiographic correlation. Radiology 1998, 208:353-357.
12. Caillé J.M., Lemanceau B., Bonnemain B. Gadolinium as a contrast agent for NMR. Am J Neuroradiol 1983, 4:1041-1042.
13. Penfield J.G., Reilly R.F. What nephrologists need to know about gadolinium. Nat Clin Pract Neph 2007, 3:654-668.
14. Bousquet J.C., Saini S., Stark D.D., Hahn P.F., Nigam M., Wittenberg J., et al. Gd-DOTA: characterization of a new paramagnetic complex. Radiology 1988, 166:693-698.
15. 3-assembled silica nanocomposite targeted nanoprobes and their application in MRI. Biomaterials 2012, 33:6438-6446.
16. Park Y.I., Kim J.H., Lee K.T., Jeon K.-S., Na H.B., Yu J.H., et al. Nonblinking and nonbleaching upconverting nanoparticles as an optical imaging nanoprobe and T1 magnetic resonance imaging contrast agent. Adv Mater 2009, 21:4467-4471.
17. Ju Q., Tu D., Liu Y., Li R., Zhu H., Chen J., et al. Amine-functionalized lanthanide-doped KGdF4 nanocrystals as potential optical/magnetic multimodal bioprobes. JAm Chem Soc 2011, 134:1323-1330.
18. Park M., Lee N., Choi S.H., An K., Yu S.-H., Kim J.H., et al. Large-scale synthesis of ultrathin manganese oxide nanoplates and their applications to T1 MRI contrast agents. Chem Mater 2011, 23:3318-3324.
19. 4 nanoparticles: insights into their T1 MRI contrast enhancement. Chem Mater 2011, 23:3714-3722.
20. Le Duc G., Miladi I., Alric C., Mowat P., Bräuer-Krisch E., Bouchet A., et al. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano 2011, 5:9566-9574.
21. Park J.Y., Baek M.J., Choi E.S., Woo S., Kim J.H., Kim T.J., et al. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and invivo T1 MR images. ACS Nano 2009, 3:3663-3669.
22. 3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning. Nanotechnology 2007, 18(39):5501-5509. Shao Y, Tian X, Hu W, Zhang Y, Liu H, He H, etal. The properties of Gd2O3-assembled silica nanocomposite targeted nanoprobes and their application in MRI. Biomaterials 2012;33:6438-46.
23. Bridot J.-L., Faure A.-C., Laurent S., Rivière C., Billotey C., Hiba B., et al. Hybrid gadolinium oxide nanoparticles:multimodal contrast agents for invivo imaging. JAm Chem Soc 2007, 129:5076-5084.
24. 3 nanocrystals: a bifunctional material with combined fluorescent labeling and MRI contrast agent properties. JPhys Chem C 2009, 113:6913-6920.
25. 3 nanoparticles inside single-wall carbon nanohorns. JPhys Chem B 2006, 110:5179-5181.
26. Kim D., Lee N., Park M., Kim B.H., An K., Hyeon T. Synthesis of uniform ferrimagnetic magnetite nanocubes. JAm Chem Soc 2008, 131:454-455.
27. Wang F., Han Y., Lim C.S., Lu Y., Wang J., Xu J., et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463:1061-1065.
28. Koole R., Schapotschnikow P., de Mello Donegá C., Vlugt T.J.H., Meijerink A. Time-dependent photoluminescence spectroscopy as a tool to measure the ligand exchange kinetics on a quantum dot surface. ACS Nano 2008, 2:1703-1714.
29. Das G.K., Heng B.C., Ng S.-C., White T., Loo J.S.C., D'Silva L., et al. Gadolinium oxide ultranarrow nanorods as multimodal contrast agents for optical and magnetic resonance imaging. Langmuir 2010, 26:8959-8965.
30. Fang J., Guo Y., Lu G., Raston C.L., Iyer K.S. Instantaneous crystallization of ultrathin one-dimensional fluorescent rhabdophane nanowires at room temperature. Green Chem 2011, 13:817-819.
31. 3+ nanocrystals by carbon nanotube induced suppression of the 1-dimensional growth. Dalton Trans 2011, 3122-3124.
32. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Inter Ed 2008, 47:8438-8441.
33. Li L., Liu C., Zhang L., Wang T., Yu H., Wang C., et al. Multifunctional magnetic-fluorescent eccentric-(concentric-Fe3O4@SiO2)@polyacrylic acid core-shell nanocomposites for cell imaging and pH-responsive drug delivery. Nanoscale 2013, 5:2249-2253.
34. Yang D., Ma J., Gao M., Peng M., Luo Y., Hui W., et al. Suppression of composite nanoparticle aggregation through steric stabilization and ligand exchange for colorimetric protein detection. RSC Adv 2013, 3:9681-9686.
35. 3+ nanoparticles. Nanoscale 2010, 2:771-777.
36. Wang H., Qiao X., Chen J., Wang X., Ding S. Mechanisms of PVP in the preparation of silver nanoparticles. Mater Chem Phys 2005, 94:449-453.
37. 3 nanocrystals functionalised by organic acids. JColloid Interface Sci 2005, 288:140-148.
38. Ravin H.A., Seligman A.M., Fine J. Polyvinyl pyrrolidone as a plasma expander. NEngl J Med 1952, 247:921-929.
39. Reimer P., Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 1998, 8:1198-1204.
40. Regoeczi E. Labelled polyvinylpyrrolidone as an invivo indicator of reticuloendothelial activity. Br J Exp Pathol 1976, 57:431-442.